Please note, this OEL/ADE monograph also applies to Cefixime trihydrate (CAS RN 125110-14-7) and Cefixime anhydrous disodium (CAS RN 79350-82-6). Cefixime is an antibiotic used to treat infections in the urinary tract, ear, tonsils, lung, and to treat gonorrhea. Cefixime is a cephalosporin antibiotic that acts by inhibiting the synthesis of the bacterial cell wall. Because it is resistant to beta-lactamase, it may work on organisms resistant to penicillin’s and other cephalosporin’s.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Cefixime, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.